Provisional standardization of hepcidin assays: Creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material
Diepeveen, L. E.; Laarakkers, C. M. M.; Martos, G.et al.
2018 • In Clinical Chemistry and Laboratory Medicine
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Diepeveen, L. E.; Department of Laboratory Medicine, Radboud University Medical Center, Translational Metabolic Laboratory (830), P.O. Box 9101, Nijmegen, 6500 HB, Netherlands, Hepcidinanalysis.com, Nijmegen, Netherlands
Laarakkers, C. M. M.; Department of Laboratory Medicine, Radboud University Medical Center, Translational Metabolic Laboratory (830), P.O. Box 9101, Nijmegen, 6500 HB, Netherlands, Hepcidinanalysis.com, Nijmegen, Netherlands
Martos, G.; Laboratoire National de Métrologie et d'Essais (LNE), Paris, France, Departement de Chimie, Bureau International des Poids et Mesures (BIPM), Sèvres, France
Pawlak, M. E.; Department of Laboratory Medicine, Radboud University Medical Center, Translational Metabolic Laboratory (830), P.O. Box 9101, Nijmegen, 6500 HB, Netherlands
Uǧuz, F. F.; Department of Laboratory Medicine, Radboud University Medical Center, Translational Metabolic Laboratory (830), P.O. Box 9101, Nijmegen, 6500 HB, Netherlands
Verberne, K. E. S. A.; Department of Laboratory Medicine, Radboud University Medical Center, Translational Metabolic Laboratory (830), P.O. Box 9101, Nijmegen, 6500 HB, Netherlands
Van Swelm, R. P. L.; Department of Laboratory Medicine, Radboud University Medical Center, Translational Metabolic Laboratory (830), P.O. Box 9101, Nijmegen, 6500 HB, Netherlands, Hepcidinanalysis.com, Nijmegen, Netherlands
Klaver, S.; Department of Laboratory Medicine, Radboud University Medical Center, Translational Metabolic Laboratory (830), P.O. Box 9101, Nijmegen, 6500 HB, Netherlands, Hepcidinanalysis.com, Nijmegen, Netherlands
De Haan, A. F. J.; Department for Health Evidence, Radboud University Medical Center, Nijmegen, Netherlands
Pitts, K. R.; Corgenix Medical Corporation, Broomfield, CO, United States
Bansal, S. S.; Institute of Pharmaceutical Sciences, King's College London, London, United Kingdom
Abbas, I. M.; Division 1.5 Protein Analysis, Federal Institute for Materials Research and Testing (BAM), Berlin, Germany
Fillet, Marianne ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
Lefebvre, T.; French Center of Porphyria, INSERM U1149, Sorbonne Paris Cité University, Labex GR-Ex, Louis Mourier Hospital APHP, Colombes, France
Geurts-Moespot, A. J.; Department of Laboratory Medicine, Radboud University Medical Center, Translational Metabolic Laboratory (830), P.O. Box 9101, Nijmegen, 6500 HB, Netherlands
Girelli, D.; Department of Medicine, University of Verona, Verona, Italy
Castagna, A.; Department of Medicine, University of Verona, Verona, Italy
Herkert, M.; DRG Instruments, Marburg, Germany
Itkonen, O.; Laboratory Division HUSLAB, Helsinki University Central Hospital, Helsinki, Finland
Olbina, G.; Intrinsic Life Sciences, San Diego, CA, United States
Tomosugi, N.; Division of Advanced Medicine, Kanazawa Medical University, Ishikawa, Japan
Westerman, M. E.; Intrinsic Life Sciences, San Diego, CA, United States
Delatour, V.; Laboratoire National de Métrologie et d'Essais (LNE), Paris, France
Weykamp, C. W.; Department of Clinical Chemistry, Queen Beatrix Hospital, Winterswijk, Netherlands
Swinkels, D. W.; Department of Laboratory Medicine, Radboud University Medical Center, Translational Metabolic Laboratory (830), P.O. Box 9101, Nijmegen, 6500 HB, Netherlands, Hepcidinanalysis.com, Nijmegen, Netherlands
Provisional standardization of hepcidin assays: Creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material
Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-3.
Girelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron disorders. Blood 2016;127:2809-13.
Kroot JJ, Kemna EH, Bansal SS, Busbridge M, Campostrini N, Girelli D, et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: Need for standardization. Haematologica 2009;94:1748-52.
Kroot JJ, van Herwaarden AE, Tjalsma H, Jansen RT, Hendriks JC, Swinkels DW. Second round robin for plasma hepcidin methods: First steps toward harmonization. Am J Hematol 2012;87: 977-83.
van der Vorm LN, Hendriks JC, Laarakkers CM, Klaver S, Armitage AE, Bamberg A, et al. Toward worldwide hepcidin assay harmonization: Identification of a commutable secondary reference material. Clin Chem 2016;62:993-1001.
Vesper HW, Myers GL, Miller WG. Current practices and challenges in the standardization and harmonization of clinical laboratory tests. Am J Clin Nutr 2016;104:907S-12S.
Hoofnagle AN. Harmonization of blood-based indicators of iron status: Making the hard work matter. Am J Clin Nutr 2017;106:1615s-9s.
ISO17511:2003. In vitro diagnostic medical devices-measurement of quantities in biological samples-metrological traceability of values assigned to calibrators and control materials. https://www.iso.org/standard/30716.html. Accessed: 10 Sept 2018.
Miller WG. Harmonization: Its time has come. Clin Chem 2017;63:1184-6.
Myers GL, Miller WG. The international consortium for harmonization of clinical laboratory results (ichclr)-a pathway for harmonization. Ejifcc 2016;27:30-6.
Myers GL, Miller WG. The roadmap for harmonization: Status of the international consortium for harmonization of clinical laboratory results. Clin Chem Lab Med 2018;56:1667-72.
Weykamp C, Eckfeld J, Vesper H, Thienpont L, Burns C, Caliendo A, et al. AACC harmonization initiative; toolbox of technical procedures to achieve harmonization for a measurand 2012. www.harmonization.net. Accessed: 10 Sept 2018.
Bros P, Josephs RD, Stoppacher N, Cazals G, Lehmann S, Hirtz C, et al. Impurity determination for hepcidin by liquid chromatography-high resolution and ion mobility mass spectrometry for the value assignment of candidate primary calibrators. Anal Bioanal Chem 2017;409:2559-67.
Laarakkers CM, Wiegerinck ET, Klaver S, Kolodziejczyk M, Gille H, Hohlbaum AM, et al. Improved mass spectrometry assay for plasma hepcidin: Detection and characterization of a novel hepcidin isoform. PLoS One 2013;8:e75518.
Pechlaner R, Kiechl S, Mayr M, Santer P, Weger S, Haschka D, et al. Correlates of serum hepcidin levels and its association with cardiovascular disease in an elderly general population. Clin Chem Lab Med 2016;54:151-61.
Murao N, Ishigai M, Yasuno H, Shimonaka Y, Aso Y. Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up. Rapid Commun Mass Spectrom 2007;21:4033-8.
Udali S, Castagna A, Corbella M, Ruzzenente A, Moruzzi S, Mazzi F, et al. Hepcidin and DNA promoter methylation in hepatocellular carcinoma. Eur J Clin Invest 2018;48.
Itkonen O, Parkkinen J, Stenman UH, Hamalainen E. Preanalytical factors and reference intervals for serum hepcidin lc-ms/ms method. Clin Chim Acta 2012;413:696-701.
Lefebvre T, Dessendier N, Houamel D, Ialy-Radio N, Kannengiesser C, Manceau H, et al. Lc-ms/ms method for hepcidin-25 measurement in human and mouse serum: Clinical and research implications in iron disorders. Clin Chem Lab Med 2015;53:1557-67.
Abbas IM, Hoffmann H, Montes-Bayon M, Weller MG. Improved lc-ms/ms method for the quantification of hepcidin-25 in clinical samples. Anal Bioanal Chem 2018;410:3835-46.
Kroot JJ, Laarakkers CM, Geurts-Moespot AJ, Grebenchtchikov N, Pickkers P, van Ede AE, et al. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem 2010;56:1570-9.
Zipperer E, Post JG, Herkert M, Kundgen A, Fox F, Haas R, et al. Serum hepcidin measured with an improved elisa correlates with parameters of iron metabolism in patients with myelodysplastic syndrome. Ann Hematol 2013;92:1617-23.
Butterfield AM, Luan P, Witcher DR, Manetta J, Murphy AT, Wroblewski VJ, et al. A dual-monoclonal sandwich elisa specific for hepcidin-25. Clin Chem 2010;56:1725-32.
Budd JR, Weykamp C, Rej R, MacKenzie F, Ceriotti F, Greenberg N, et al. IFCC working group recommendations for assessing commutability part 3: Using the calibration effectiveness of a reference material. Clin Chem 2018;64:465-74.
Fraser CG, Hyltoft Petersen P, Libeer JC, Ricos C. Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 1997;34:8-12.
Murphy AT, Witcher DR, Luan P, Wroblewski VJ. Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood 2007;110:1048-54.
ISO13528:2005. Statistical methods for use in proficiency testing by interlaboratory comparisons. https://www.iso.org/standard/35664.html. Accessed: 10 Sept 2018.
ISO/IECGuide98-3:2008. Uncertainty of measurement-part 3: Guide to the expression of uncertainty in measurement (gum:1995). https://www.iso.org/standard/50461.html. Accessed: 10 Sept 2018.
Kroot JJ, Hendriks JC, Laarakkers CM, Klaver SM, Kemna EH, Tjalsma H, et al. (Pre)analytical imprecision, between-subject variability, daily variations in serum and urine hepcidin: Implications for clinical studies. Anal Biochem 2009; 389:124-9.
Schaap CC, Hendriks JC, Kortman GA, Klaver SM, Kroot JJ, Laarakkers CM, et al. Diurnal rhythm rather than dietary iron mediates daily hepcidin variations. Clin Chem 2013; 59:527-35.
Kemna E, Tjalsma H, Laarakkers C, Nemeth E, Willems H, Swinkels D. Novel urine hepcidin assay by mass spectrometry. Blood 2005;106:3268-70.
Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood 2008;112:4292-7.